Clin2
NCT07035444Possibly a fitNot yet recruiting

L-carnitine nutrition for weight loss in lung cancer

Non-Small Cell Lung CancerCachexia

Treatments studied

Part of Cancer, Lungs & breathing clinical trials.

This trial tests if adding L-carnitine to liquid nutrition can help people with non-small cell lung cancer who are losing weight and muscle mass. It is for those who are on chemotherapy and have lost weight recently.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
126 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have non-small cell lung cancer that is confirmed by a biopsy.
  • You have significant weight loss or low muscle mass related to your cancer.
  • You are age 18 or older and are about to start or are currently on chemotherapy.
  • You have adequate organ function (kidney, liver, blood counts) based on recent tests.
  • You do not have uncontrolled diabetes, serious heart problems, or conditions that prevent taking nutrition by mouth or tube.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04627376Recruiting
Program to help prevent cancer-related weight and muscle loss

This trial tests a “multimodal” program meant to help people with cancer avoid developing cachexia, a condition that causes unwanted weight and muscle loss. It may help you stay stronger and maintain weight if you are not yet in advanced or rapidly worsening stages.

Limassol
NCT07185308Not yet recruiting
Postbiotics for weight loss in advanced lung cancer

This trial tests whether a postbiotic supplement can help people with advanced non-small-cell lung cancer who are losing weight (cachexia). If you're getting or have finished chemotherapy plus immunotherapy for stage III or IV NSCLC and have lost weight recently, you may be able to join.

Chongqing, Chongqing Municipality
NCT06961201Not yet recruiting· Phase 3
Appetite medicine study for lung cancer with weight loss

This trial tests a new appetite-boosting medicine (nano-crystalline megestrol acetate) added to standard chemotherapy for people with advanced small cell lung cancer who are losing weight. It aims to see if it helps with weight, strength, and treatment response.

Chengdu, Sichuan
NCT07642076Recruiting· Phase 4
L-carnitine supplement for critically ill liver disease patients

This study tests whether adding L-carnitine (a naturally occurring compound) to standard care helps people with serious liver disease who are in the intensive care unit. L-carnitine may help the body use energy better and reduce complications from liver failure.

Menoufia
NCT06073431Recruiting
Study on weight loss types in advanced cancer

This study looks at different types of weight loss (cachexia) in people with advanced lung, pancreatic, or colorectal cancer. Researchers want to find patterns to better understand and treat it. You can join even if you haven't lost weight yet.

Fort Smith, Arkansas
NCT06212765Not yet recruiting· Phase 3
Citrulline Supplement for COPD Patients with Weight Loss

This trial tests if taking oral citrulline (a supplement) can help improve nutrition and muscle strength in people with advanced COPD who are underweight and have muscle loss. If you have severe COPD and are losing weight or muscle, this study may be a way to see if citrulline can help you feel stronger and healthier.

Hear when a new Non Small Cell Lung Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.